M EVR7 Pill - white capsule/oblong, 12mm
Pill with imprint M EVR7 is White, Capsule/Oblong and has been identified as Everolimus 7.5 mg. It is supplied by Mylan Pharmaceuticals Inc.
Everolimus is used in the treatment of Neuroendocrine Tumors; Breast Cancer; Tuberous Sclerosis Complex; Organ Transplant, Rejection Prophylaxis; Renal Angiomyolipoma and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M EVR7
Everolimus
- Imprint
- M EVR7
- Strength
- 7.5 mg
- Color
- White
- Size
- 12.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- MTOR inhibitors, Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-3098
Related images for "M EVR7"
More about everolimus
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (29)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: mTOR inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Afinitor, Zortress, Afinitor Disperz
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.